Skip to main content
Search

Beijing Friendship Hospital

2 related articles

Subscribe to updates
  1. The FASEB Journal

    Integrating Metabolomics, Mendelian Randomization, and Machine Learning, a Study Flags Phenylalanine and Its Transporter SLC6A14 as Candidate Diagnostic and Therapeutic Targets in Pancreatic Cancer

    Integrating plasma metabolomics, Mendelian randomization, and machine learning, this study identified phenylalanine as causally associated with pancreatic cancer among 55 plasma metabolites (IVW OR = 1.641, 95% CI 1.052–2.562, p = 0.029), derived eight related differentially expressed genes, built a random forest diagnostic model from 113 combinations of 12 algorithms (training AUC 0.994; validation AUCs 0.918, 0.983, 0.923), used SHAP to rank SLC6A14 as the top feature, and combined single-cell sequencing, simulated gene knockout, molecular docking, and molecular dynamics to suggest genistein binds SLC6A14 stably, with RT-qPCR confirming high expression of the five model genes in a BxPC-3 versus HPDE6-C7 cell pair.

  2. Non-invasive tests for early-stage liver fibrosis: current advances and challenges

    This review systematically evaluates established and emerging non-invasive tests for detecting early-stage liver fibrosis (F1–F2), spanning serum biomarkers, molecular imaging probes, AI-based analysis of conventional imaging, alternative biofluids such as urine, exhaled breath and saliva, gut microbiota-derived biomarkers, and multiomics-integrated models, concluding that these approaches show diagnostic promise but remain constrained by limited validation, absent standardization, and unclear integration into clinical pathways, and proposing a tiered diagnostic framework as a near-term implementation route.

You’re all caught up